American scientists Victor Ambros and Gary Ruvkun have won the 2024 Nobel Prize in Physiology or Medicine for their groundbreaking discovery of microRNA, a small but powerful molecule that plays a crucial role in gene regulation.
Their groundbreaking research has unveiled new insights into how cells in the body operate and has implications for understanding complex diseases like cancer.
A New Frontier in Gene Regulation
The Nobel Prize committee in Sweden praised the discovery, calling it a “groundbreaking revelation” that opened up “an entirely new dimension of gene regulation.” Ambros, a natural science professor at the University of Massachusetts Medical School, and Ruvkun, a genetics professor at Harvard Medical School, have devoted decades to investigating how microRNA regulates cellular processes by controlling the expression of specific genes.
The discovery of gene regulation by microRNA has transformed biological research. These molecules act as switches that control the types of proteins cells produce, influencing everything from cell development to the formation of complex tissues.
How Cells Work Differently?
All cells in the human body carry the same genetic information yet perform vastly different functions. Muscle cells and nerve cells, for example, have different characteristics despite sharing the same DNA. Ambros and Ruvkun’s research into gene regulation provides the answer: gene regulation allows each cell to “read” only the relevant instructions needed for its specific function.
The Nobel committee states that this regulation guarantees the activation of the correct set of genes in each cell type, which is crucial for the body’s proper functioning.
Implications for Evolution and Disease
The discovery of microRNA has significant implications for understanding how organisms evolve and how diseases develop. Research demonstrates that microRNA aids in the regulation of intricate biological processes and contributes to the evolution of multicellular organisms. However, when gene regulation by microRNA goes wrong, it can lead to severe conditions, including cancer, hearing loss, and skeletal disorders.
Thomas Perlmann, the secretary-general of the Nobel Assembly, stated that microRNAs play a significant role in cancer. Researchers are exploring how microRNA-based therapies could potentially target and treat various cancers, although clinical applications are still under development.
From ‘Oddity’ to Fundamental Discovery
Ambros and Ruvkun’s early work focused on a tiny roundworm called C. elegans, which has many specialized cell types despite its small size. Ambros initially dismissed the discovery of the first microRNA in these worms in 1993 as an oddity with little relevance to other species. It wasn’t until Ruvkun discovered another microRNA that scientists realized these molecules were present throughout the animal kingdom.
This breakthrough led to an explosion of research, with thousands of microRNAs now identified in various organisms, from plants to humans.
Revolutionary Impact on Science and Medicine
Given the transformative impact of their research, people have been anticipating Ambros and Ruvkun’s recognition for years. Researchers are currently exploring the potential of microRNAs in diagnosing and treating diseases such as cancer. Clinical trials are underway to utilize microRNA profiling for patient prognosis and responses to treatment.
Janosch Heller, an assistant professor in biomedical sciences at Dublin City University, described the discovery as a revelation that “opened our eyes to the wonderful machinery that tightly controls cellular functions.
Joshua Rosenthal, a senior scientist at the Marine Biological Laboratory, highlighted the importance of microRNAs in explaining why organisms with similar numbers of genes, such as worms and humans, can have vastly different levels of complexity. “MicroRNAs, once discarded as insignificant, are now known to be key regulators of genes in virtually every cell and tissue,” he said.
Previous Nobel Laureates and Recognition
Katalin Karikó and Drew Weissman won the Nobel Prize in Physiology or Medicine last year for their work on mRNA vaccines, which significantly contributed to the fight against the COVID-19 pandemic. This year’s winners, Ambros and Ruvkun, will share the 11 million Swedish kronor ($1 million) prize for their contribution to our understanding of gene regulation.
Their work not only advances the field of biology but also holds the promise of improving medical treatments in the future. While it may take years for these findings to translate into clinical therapies, the Nobel Assembly emphasized the fundamental importance of this discovery for the future of medicine.
